APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation General Anesthesia Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Inhalation General Anesthesia Drugs Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchInhalation General Anesthesia Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation General Anesthesia Drugs Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Inhalation General Anesthesia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation General Anesthesia Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation General Anesthesia Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Inhalation General Anesthesia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Inhalation General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Inhalation General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Inhalation General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Inhalation General Anesthesia Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Inhalation General Anesthesia Drugs include AbbVie, Baxter, LAB UNKNOWN, Maruishi, Piramal, PT Novell Pharmaceutical, Viatris and Hengrui, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Inhalation General Anesthesia Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Inhalation General Anesthesia Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Inhalation General Anesthesia Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Inhalation General Anesthesia Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Inhalation General Anesthesia Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Inhalation General Anesthesia Drugs sales, projected growth trends, production technology, application and end-user industry.

Inhalation General Anesthesia Drugs Segment by Company

AbbVie

Baxter

LAB UNKNOWN

Maruishi

Piramal

PT Novell Pharmaceutical

Viatris

Hengrui

Inhalation General Anesthesia Drugs Segment by Type

Isoflurane

Sevoflurane

Other

Inhalation General Anesthesia Drugs Segment by Application

Hospital

Clinic

Other

Inhalation General Anesthesia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation General Anesthesia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation General Anesthesia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation General Anesthesia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Inhalation General Anesthesia Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Inhalation General Anesthesia Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhalation General Anesthesia Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Inhalation General Anesthesia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Isoflurane Major Manufacturers Table 3. Sevoflurane Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Inhalation General Anesthesia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Inhalation General Anesthesia Drugs Industry Trends Table 10. Inhalation General Anesthesia Drugs Industry Drivers Table 11. Inhalation General Anesthesia Drugs Industry Opportunities and Challenges Table 12. Inhalation General Anesthesia Drugs Industry Restraints Table 13. Global Inhalation General Anesthesia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Inhalation General Anesthesia Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Inhalation General Anesthesia Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Inhalation General Anesthesia Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026) & (K Units) Table 20. Global Inhalation General Anesthesia Drugs Sales by Region (2027-2032) & (K Units) Table 21. Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2021-2026) Table 22. Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2027-2032) Table 23. Global Inhalation General Anesthesia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Inhalation General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Inhalation General Anesthesia Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Inhalation General Anesthesia Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Inhalation General Anesthesia Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Inhalation General Anesthesia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Inhalation General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Inhalation General Anesthesia Drugs Manufacturers, Product Type & Application Table 31. Global Inhalation General Anesthesia Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Inhalation General Anesthesia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Inhalation General Anesthesia Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Inhalation General Anesthesia Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 41. Global Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 42. Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2021-2026) Table 43. Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2027-2032) Table 44. Global Inhalation General Anesthesia Drugs Price by Type (2021-2026) & (US$/Unit) Table 45. Global Inhalation General Anesthesia Drugs Price by Type (2027-2032) & (US$/Unit) Table 46. Global Inhalation General Anesthesia Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Inhalation General Anesthesia Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 54. Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2021-2026) Table 55. Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2027-2032) Table 56. Global Inhalation General Anesthesia Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhalation General Anesthesia Drugs Price by Application (2027-2032) & (US$/Unit) Table 58. AbbVie Company Information Table 59. AbbVie Business Overview Table 60. AbbVie Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. AbbVie Inhalation General Anesthesia Drugs Product Portfolio Table 62. AbbVie Recent Development Table 63. Baxter Company Information Table 64. Baxter Business Overview Table 65. Baxter Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Baxter Inhalation General Anesthesia Drugs Product Portfolio Table 67. Baxter Recent Development Table 68. LAB UNKNOWN Company Information Table 69. LAB UNKNOWN Business Overview Table 70. LAB UNKNOWN Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio Table 72. LAB UNKNOWN Recent Development Table 73. Maruishi Company Information Table 74. Maruishi Business Overview Table 75. Maruishi Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Maruishi Inhalation General Anesthesia Drugs Product Portfolio Table 77. Maruishi Recent Development Table 78. Piramal Company Information Table 79. Piramal Business Overview Table 80. Piramal Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Piramal Inhalation General Anesthesia Drugs Product Portfolio Table 82. Piramal Recent Development Table 83. PT Novell Pharmaceutical Company Information Table 84. PT Novell Pharmaceutical Business Overview Table 85. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio Table 87. PT Novell Pharmaceutical Recent Development Table 88. Viatris Company Information Table 89. Viatris Business Overview Table 90. Viatris Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Viatris Inhalation General Anesthesia Drugs Product Portfolio Table 92. Viatris Recent Development Table 93. Hengrui Company Information Table 94. Hengrui Business Overview Table 95. Hengrui Inhalation General Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hengrui Inhalation General Anesthesia Drugs Product Portfolio Table 97. Hengrui Recent Development Table 98. North America Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 101. North America Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 102. North America Inhalation General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Inhalation General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 107. North America Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 108. North America Inhalation General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Inhalation General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 115. North America Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 116. North America Inhalation General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Inhalation General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 119. Canada Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 120. Mexico Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 121. Europe Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 124. Europe Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 125. Europe Inhalation General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Europe Inhalation General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Europe Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 130. Europe Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 131. Europe Inhalation General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Europe Inhalation General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Europe Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 138. Europe Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 139. Europe Inhalation General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Europe Inhalation General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Germany Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 142. France Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 143. U.K. Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 144. Italy Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 145. Russia Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 146. Spain Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 149. Sweden Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 150. Poland Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 151. China Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 152. China Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 153. China Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 154. China Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 155. China Inhalation General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 156. China Inhalation General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 157. China Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 158. China Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 159. China Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 160. China Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 161. China Inhalation General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 162. China Inhalation General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 166. Asia Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 167. Asia Inhalation General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 168. Asia Inhalation General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 169. Asia Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 172. Asia Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 173. Asia Inhalation General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 174. Asia Inhalation General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. Asia Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 180. Asia Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 181. Asia Inhalation General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 182. Asia Inhalation General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Japan Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 184. South Korea Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 185. India Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 186. Australia Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Inhalation General Anesthesia Drugs Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Inhalation General Anesthesia Drugs Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Inhalation General Anesthesia Drugs Sales by Type (2021-2026) & (K Units) Table 192. SAMEA Inhalation General Anesthesia Drugs Sales by Type (2027-2032) & (K Units) Table 193. SAMEA Inhalation General Anesthesia Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 194. SAMEA Inhalation General Anesthesia Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 195. SAMEA Inhalation General Anesthesia Drugs Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Inhalation General Anesthesia Drugs Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Inhalation General Anesthesia Drugs Sales by Application (2021-2026) & (K Units) Table 198. SAMEA Inhalation General Anesthesia Drugs Sales by Application (2027-2032) & (K Units) Table 199. SAMEA Inhalation General Anesthesia Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 200. SAMEA Inhalation General Anesthesia Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 201. SAMEA Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 205. SAMEA Inhalation General Anesthesia Drugs Sales by Country (2021-2026) & (K Units) Table 206. SAMEA Inhalation General Anesthesia Drugs Sales by Country (2027-2032) & (K Units) Table 207. SAMEA Inhalation General Anesthesia Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 208. SAMEA Inhalation General Anesthesia Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 209. Brazil Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 210. Argentina Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 211. Chile Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 212. Colombia Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 213. Peru Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 215. Israel Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 216. UAE Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 217. Turkey Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 218. Iran Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 219. Egypt Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Inhalation General Anesthesia Drugs Distributors List Table 223. Inhalation General Anesthesia Drugs Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Inhalation General Anesthesia Drugs Image Figure 2. Global Inhalation General Anesthesia Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation General Anesthesia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Isoflurane Image Figure 5. Sevoflurane Image Figure 6. Other Image Figure 7. Global Inhalation General Anesthesia Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Inhalation General Anesthesia Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Inhalation General Anesthesia Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Inhalation General Anesthesia Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Inhalation General Anesthesia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Inhalation General Anesthesia Drugs Sales (2021-2032) & (K Units) Figure 18. Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Inhalation General Anesthesia Drugs Sales YoY (2021-2032) & (K Units) Figure 21. Europe Inhalation General Anesthesia Drugs Sales YoY (2021-2032) & (K Units) Figure 22. China Inhalation General Anesthesia Drugs Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Inhalation General Anesthesia Drugs Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Inhalation General Anesthesia Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Global Inhalation General Anesthesia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Inhalation General Anesthesia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Inhalation General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Inhalation General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Inhalation General Anesthesia Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Inhalation General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Inhalation General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Inhalation General Anesthesia Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Inhalation General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 41. North America Inhalation General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 42. North America Inhalation General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 43. North America Inhalation General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 44. North America Inhalation General Anesthesia Drugs Revenue Share by Country (2021-2032) Figure 45. North America Inhalation General Anesthesia Drugs Sales Share by Country (2021-2032) Figure 46. Europe Inhalation General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Inhalation General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 48. Europe Inhalation General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Inhalation General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 50. Europe Inhalation General Anesthesia Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Inhalation General Anesthesia Drugs Sales Share by Country (2021-2032) Figure 52. China Inhalation General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 53. China Inhalation General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 54. China Inhalation General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 55. China Inhalation General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 56. Asia Inhalation General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Inhalation General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 58. Asia Inhalation General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Inhalation General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 60. Asia Inhalation General Anesthesia Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Inhalation General Anesthesia Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Inhalation General Anesthesia Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Inhalation General Anesthesia Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Inhalation General Anesthesia Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Inhalation General Anesthesia Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Inhalation General Anesthesia Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Inhalation General Anesthesia Drugs Sales Share by Country (2021-2032) Figure 68. Inhalation General Anesthesia Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Inhalation General Anesthesia Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AbbVie
  • Baxter
  • LAB UNKNOWN
  • Maruishi
  • Piramal
  • PT Novell Pharmaceutical
  • Viatris
  • Hengrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Inhalation General Anesthesia Drugs Market by Type
  3. 1.2.1 Global Inhalation General Anesthesia Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Isoflurane
  5. 1.2.3 Sevoflurane
  6. 1.2.4 Other
  7. 1.3 Inhalation General Anesthesia Drugs Market by Application
  8. 1.3.1 Global Inhalation General Anesthesia Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Inhalation General Anesthesia Drugs Market Dynamics
  1. 2.1 Inhalation General Anesthesia Drugs Industry Trends
  2. 2.2 Inhalation General Anesthesia Drugs Industry Drivers
  3. 2.3 Inhalation General Anesthesia Drugs Industry Opportunities and Challenges
  4. 2.4 Inhalation General Anesthesia Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Inhalation General Anesthesia Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Inhalation General Anesthesia Drugs Revenue by Region
  3. 3.2.1 Global Inhalation General Anesthesia Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Inhalation General Anesthesia Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Inhalation General Anesthesia Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Inhalation General Anesthesia Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Inhalation General Anesthesia Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Inhalation General Anesthesia Drugs Sales by Region
  9. 3.4.1 Global Inhalation General Anesthesia Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Inhalation General Anesthesia Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Inhalation General Anesthesia Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Inhalation General Anesthesia Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Inhalation General Anesthesia Drugs Revenue by Manufacturers
  2. 4.1.1 Global Inhalation General Anesthesia Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Inhalation General Anesthesia Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Inhalation General Anesthesia Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Inhalation General Anesthesia Drugs Sales by Manufacturers
  6. 4.2.1 Global Inhalation General Anesthesia Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Inhalation General Anesthesia Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Inhalation General Anesthesia Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Inhalation General Anesthesia Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Inhalation General Anesthesia Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Inhalation General Anesthesia Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Inhalation General Anesthesia Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Inhalation General Anesthesia Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Inhalation General Anesthesia Drugs Market CR5 and HHI
  16. 4.8.2 2025 Inhalation General Anesthesia Drugs Tier 1, Tier 2, and Tier 3
5 Inhalation General Anesthesia Drugs Market by Type
  1. 5.1 Global Inhalation General Anesthesia Drugs Revenue by Type
  2. 5.1.1 Global Inhalation General Anesthesia Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Inhalation General Anesthesia Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Inhalation General Anesthesia Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Inhalation General Anesthesia Drugs Sales by Type
  6. 5.2.1 Global Inhalation General Anesthesia Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhalation General Anesthesia Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Inhalation General Anesthesia Drugs Price by Type
6 Inhalation General Anesthesia Drugs Market by Application
  1. 6.1 Global Inhalation General Anesthesia Drugs Revenue by Application
  2. 6.1.1 Global Inhalation General Anesthesia Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Inhalation General Anesthesia Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Inhalation General Anesthesia Drugs Sales by Application
  6. 6.2.1 Global Inhalation General Anesthesia Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Inhalation General Anesthesia Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Inhalation General Anesthesia Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Inhalation General Anesthesia Drugs Price by Application
7 Company Profiles
  1. 7.1 AbbVie
  2. 7.1.1 AbbVie Company Information
  3. 7.1.2 AbbVie Business Overview
  4. 7.1.3 AbbVie Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AbbVie Inhalation General Anesthesia Drugs Product Portfolio
  6. 7.1.5 AbbVie Recent Developments
  7. 7.2 Baxter
  8. 7.2.1 Baxter Company Information
  9. 7.2.2 Baxter Business Overview
  10. 7.2.3 Baxter Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Baxter Inhalation General Anesthesia Drugs Product Portfolio
  12. 7.2.5 Baxter Recent Developments
  13. 7.3 LAB UNKNOWN
  14. 7.3.1 LAB UNKNOWN Company Information
  15. 7.3.2 LAB UNKNOWN Business Overview
  16. 7.3.3 LAB UNKNOWN Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolio
  18. 7.3.5 LAB UNKNOWN Recent Developments
  19. 7.4 Maruishi
  20. 7.4.1 Maruishi Company Information
  21. 7.4.2 Maruishi Business Overview
  22. 7.4.3 Maruishi Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Maruishi Inhalation General Anesthesia Drugs Product Portfolio
  24. 7.4.5 Maruishi Recent Developments
  25. 7.5 Piramal
  26. 7.5.1 Piramal Company Information
  27. 7.5.2 Piramal Business Overview
  28. 7.5.3 Piramal Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Piramal Inhalation General Anesthesia Drugs Product Portfolio
  30. 7.5.5 Piramal Recent Developments
  31. 7.6 PT Novell Pharmaceutical
  32. 7.6.1 PT Novell Pharmaceutical Company Information
  33. 7.6.2 PT Novell Pharmaceutical Business Overview
  34. 7.6.3 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolio
  36. 7.6.5 PT Novell Pharmaceutical Recent Developments
  37. 7.7 Viatris
  38. 7.7.1 Viatris Company Information
  39. 7.7.2 Viatris Business Overview
  40. 7.7.3 Viatris Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Viatris Inhalation General Anesthesia Drugs Product Portfolio
  42. 7.7.5 Viatris Recent Developments
  43. 7.8 Hengrui
  44. 7.8.1 Hengrui Company Information
  45. 7.8.2 Hengrui Business Overview
  46. 7.8.3 Hengrui Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hengrui Inhalation General Anesthesia Drugs Product Portfolio
  48. 7.8.5 Hengrui Recent Developments
8 North America
  1. 8.1 North America Inhalation General Anesthesia Drugs Market Size by Type
  2. 8.1.1 North America Inhalation General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Inhalation General Anesthesia Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Inhalation General Anesthesia Drugs Price by Type (2021-2032)
  5. 8.2 North America Inhalation General Anesthesia Drugs Market Size by Application
  6. 8.2.1 North America Inhalation General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Inhalation General Anesthesia Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Inhalation General Anesthesia Drugs Price by Application (2021-2032)
  9. 8.3 North America Inhalation General Anesthesia Drugs Market Size by Country
  10. 8.3.1 North America Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Inhalation General Anesthesia Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Inhalation General Anesthesia Drugs Market Size by Type
  2. 9.1.1 Europe Inhalation General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Inhalation General Anesthesia Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Inhalation General Anesthesia Drugs Price by Type (2021-2032)
  5. 9.2 Europe Inhalation General Anesthesia Drugs Market Size by Application
  6. 9.2.1 Europe Inhalation General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Inhalation General Anesthesia Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Inhalation General Anesthesia Drugs Price by Application (2021-2032)
  9. 9.3 Europe Inhalation General Anesthesia Drugs Market Size by Country
  10. 9.3.1 Europe Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Inhalation General Anesthesia Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Inhalation General Anesthesia Drugs Market Size by Type
  2. 10.1.1 China Inhalation General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Inhalation General Anesthesia Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Inhalation General Anesthesia Drugs Price by Type (2021-2032)
  5. 10.2 China Inhalation General Anesthesia Drugs Market Size by Application
  6. 10.2.1 China Inhalation General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Inhalation General Anesthesia Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Inhalation General Anesthesia Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Inhalation General Anesthesia Drugs Market Size by Type
  2. 11.1.1 Asia Inhalation General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Inhalation General Anesthesia Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Inhalation General Anesthesia Drugs Price by Type (2021-2032)
  5. 11.2 Asia Inhalation General Anesthesia Drugs Market Size by Application
  6. 11.2.1 Asia Inhalation General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Inhalation General Anesthesia Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Inhalation General Anesthesia Drugs Price by Application (2021-2032)
  9. 11.3 Asia Inhalation General Anesthesia Drugs Market Size by Country
  10. 11.3.1 Asia Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Inhalation General Anesthesia Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Inhalation General Anesthesia Drugs Market Size by Type
  2. 12.1.1 SAMEA Inhalation General Anesthesia Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Inhalation General Anesthesia Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Inhalation General Anesthesia Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Inhalation General Anesthesia Drugs Market Size by Application
  6. 12.2.1 SAMEA Inhalation General Anesthesia Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Inhalation General Anesthesia Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Inhalation General Anesthesia Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Inhalation General Anesthesia Drugs Market Size by Country
  10. 12.3.1 SAMEA Inhalation General Anesthesia Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Inhalation General Anesthesia Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Inhalation General Anesthesia Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Inhalation General Anesthesia Drugs Value Chain Analysis
  2. 13.1.1 Inhalation General Anesthesia Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Inhalation General Anesthesia Drugs Production Mode & Process
  6. 13.2 Inhalation General Anesthesia Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Inhalation General Anesthesia Drugs Distributors
  9. 13.2.3 Inhalation General Anesthesia Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst